The blood-brain barrier (BBB) tightly controls which substances move from the bloodstream into brain tissue, and neither oral glycine nor GABA should be thought of as simply flooding the brain with an inhibitory neurotransmitter after you swallow it.
Before worrying about supplements, try this for 60 seconds tonight: breathe gently through your nose for about 4 seconds, then exhale for about 6 seconds. Avoid taking unusually deep breaths. This simple shift toward slower breathing can reduce physiological arousal without requiring any substance to cross the BBB.
So which supplement crosses better? The scientifically accurate answer is more nuanced than “glycine crosses, GABA doesn’t.”
Glycine has specific transport systems at the blood-brain interface and can participate in central nervous-system signaling, but its movement is tightly regulated. GABA’s penetration into the brain from the bloodstream appears much more restricted, and whether ordinary oral GABA meaningfully raises human brain GABA remains uncertain.
Why the Blood-Brain Barrier Changes the Question
The BBB is formed largely by specialized cells surrounding the brain’s blood vessels.
Its job isn’t simply to block chemicals. It selectively regulates transport.
Some molecules diffuse across relatively easily. Others need specialized transporters, and some are actively moved back toward the bloodstream.
That distinction matters for amino-acid supplements.
Taking a neurotransmitter orally does not necessarily mean:
supplement → bloodstream → brain → more neurotransmitter activity → sleep
The body may digest or metabolize it, transport may be limited, and the compound may have important effects outside the brain.
Sleep itself is controlled by overlapping systems involving circadian timing, homeostatic sleep pressure, temperature regulation, autonomic activity, adenosine, GABA, glutamate, orexin and numerous other signals.
Glycine: It Can Reach the CNS, but Transport Is Controlled
Glycine is a small amino acid that also functions as a neurotransmitter.
Inside the nervous system, it has two especially important roles.
First, glycine acts as an inhibitory neurotransmitter, particularly in the spinal cord and brainstem. Glycine receptors are chloride channels; when activated, they generally make neurons less excitable.
Second, glycine works as a necessary co-agonist at NMDA receptors, which participate in excitatory glutamate signaling.
So glycine cannot accurately be described as simply a “calming neurotransmitter.”
Its effect depends on where it acts and which receptor system is involved.
The BBB also contains mechanisms that regulate glycine movement rather than allowing blood concentrations and brain concentrations to rise together without restriction. Experimental research indicates that glycine transport across brain endothelial systems is tightly controlled, including mechanisms capable of removing glycine from the brain.
This is one reason the claim that supplemental glycine works for sleep simply because it “crosses the BBB easily” is too simplistic.
GABA: Brain Entry Appears Much More Restricted
Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the adult human brain.
When GABA activates its receptors, it can decrease neuronal excitability. Many sedative medications influence GABA signaling—but that does not mean oral GABA supplements behave like those drugs.
The key problem is BBB permeability.
Experimental evidence has long suggested that circulating GABA crosses the BBB poorly under normal conditions. A review examining oral GABA noted that studies have produced conflicting findings about BBB penetration and that evidence demonstrating substantial brain entry in humans is lacking.
A systematic review of human trials subsequently found limited evidence for stress benefits and very limited evidence for sleep benefits from oral GABA.
That doesn’t necessarily mean oral GABA does nothing.
It means that “I swallowed GABA, therefore my brain received a large dose of GABA” is not established physiology.
Could GABA Work Without Crossing Deep Into the Brain?
Possibly.
This is one of the more interesting unanswered questions.
Researchers have proposed that orally consumed GABA might influence physiology through peripheral GABA receptors, the enteric nervous system or gut-brain signaling, rather than requiring large quantities to enter brain tissue directly.
Another possibility involves brain regions where the blood-brain interface differs from the classic BBB.
But these mechanisms remain incompletely understood.
So when someone reports relaxation after taking GABA, their experience should not automatically be dismissed—but it also doesn’t prove that the supplement crossed the BBB and directly increased synaptic GABA.
Which One Crosses Better?
If the question is strictly about BBB physiology, glycine has a clearer established system for regulated transport at the blood-brain interface than GABA.
But “crosses better” can still be misleading.
Glycine concentrations in the central nervous system are carefully controlled by transporters. More glycine in the bloodstream doesn’t necessarily produce a proportional increase throughout the brain.
GABA appears substantially restricted by the BBB, and there is currently insufficient human evidence to claim that typical oral supplementation efficiently raises brain GABA.
Most importantly, BBB penetration alone does not tell us which supplement will improve sleep.
Those are separate questions.
What Is Well-Established?
Well-established
GABA is an important inhibitory neurotransmitter in the central nervous system.
Glycine functions both as an inhibitory neurotransmitter and as a co-agonist involved in NMDA-receptor signaling.
Both substances are subject to biological transport and regulation; neither should be treated as a simple direct pipeline from capsule to synapse.
Plausible
Small human studies suggest that glycine taken before bedtime may influence sleep-related physiology and subjective sleep quality.
For example, controlled studies have reported improvements in some subjective sleep measures and next-day fatigue after 3 grams of glycine before bedtime. Experimental work has also suggested that glycine’s sleep-related effects may involve thermoregulation.
These findings are interesting but come from a relatively small evidence base.
Uncertain
Whether ordinary oral GABA supplementation substantially increases GABA concentrations inside the human brain remains unresolved.
It is also uncertain whether either supplement produces meaningful improvements in chronic insomnia. Neither has an evidence base comparable with established behavioral treatment for chronic insomnia, particularly cognitive behavioral therapy for insomnia (CBT-I).
Three Common Mistakes
- Assuming BBB penetration equals effectiveness. A compound could enter the brain and still have little useful effect on sleep. Conversely, a substance could potentially influence sleep indirectly without extensively entering brain tissue.
- Thinking glycine is simply “another GABA.” Glycine has multiple functions, including participation in excitatory NMDA-receptor signaling. Its physiology is more complicated than a calming-versus-stimulating label.
- Increasing doses until sedation appears. Supplement effects are not necessarily linear. More isn’t automatically more effective, and combining multiple sedating supplements makes both benefits and adverse effects harder to interpret.
A More Useful Evening Strategy
If you’re experimenting with sleep supplements, first stabilize the variables that have stronger physiological foundations.
In the hours before bedtime, avoid late caffeine and excessive bright light if either interferes with your sleep.
Closer to bedtime, allow your environment and body to transition toward sleep: reduce unnecessary stimulation and keep the bedroom comfortably cool.
Then evaluate one intervention at a time rather than stacking glycine, GABA, melatonin, valerian and several other ingredients simultaneously.
If sleep improves, you have a much better chance of understanding what actually changed.
Persistent insomnia deserves a broader approach rather than an endless search for the neurotransmitter supplement with the best BBB penetration.
What This Doesn’t Mean
It doesn’t mean glycine is proven to be the better sleep supplement.
It doesn’t mean oral GABA is useless simply because its BBB penetration appears limited.
And it doesn’t mean that increasing inhibitory neurotransmitters is always the solution to insomnia.
Difficulty sleeping can involve circadian timing, conditioned arousal, insufficient sleep pressure, medications, substances, environmental factors and medical or psychological conditions. Neurotransmitter biology is only one part of that system.
Bottom Line
GABA does not appear to cross the blood-brain barrier efficiently under normal conditions, and evidence that oral GABA substantially increases brain GABA in humans remains weak.
Glycine has established transport mechanisms at the blood-brain interface, but its movement into and out of the nervous system is tightly regulated. Saying that glycine simply “crosses the BBB easily” therefore overstates the science.
Small studies provide some evidence that glycine may improve certain sleep-related outcomes, while evidence for oral GABA and sleep is more limited.
For sleep, however, blood-brain barrier penetration isn’t the contest that matters most. The useful question is whether a particular intervention produces a meaningful, reproducible improvement in sleep with acceptable risk—and for both supplements, the evidence remains considerably more modest than many product claims suggest.